+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Daptomycin"

From
From
Peptide Antibiotics Global Market Report 2024 - Product Thumbnail Image

Peptide Antibiotics Global Market Report 2024

  • Report
  • December 2023
  • 200 Pages
  • Global
From
From
Global and Chinese Daptomycin Industry, 2021 Market Research Report - Product Thumbnail Image

Global and Chinese Daptomycin Industry, 2021 Market Research Report

  • Report
  • January 2021
  • 143 Pages
  • China, Global
From
Antibiotic Drug Resistance. Edition No. 1 - Product Thumbnail Image

Antibiotic Drug Resistance. Edition No. 1

  • Book
  • October 2019
  • 720 Pages
  • 10 Results (Page 1 of 1)
Loading Indicator

Daptomycin is an antibiotic used to treat a variety of bacterial infections. It is a lipopeptide antibiotic, which means it is composed of both a lipid and a peptide. It works by disrupting the cell membrane of the bacteria, causing it to become leaky and eventually die. Daptomycin is used to treat skin and soft tissue infections, as well as complicated and serious infections such as endocarditis and bacteremia. It is also used to treat infections caused by methicillin-resistant Staphylococcus aureus (MRSA). Daptomycin is generally well-tolerated and has few side effects. It is usually administered intravenously, but can also be given orally in some cases. It is often used in combination with other antibiotics to treat more serious infections. The daptomycin market is a growing segment of the antibiotics market. It is used to treat a variety of bacterial infections, and is generally well-tolerated with few side effects. It is often used in combination with other antibiotics to treat more serious infections. Some companies in the daptomycin market include Cubist Pharmaceuticals, Merck, Pfizer, and Novartis. Show Less Read more